Immune self-reactivity triggered by drug-modified HLA-peptide repertoire - PubMed (original) (raw)

. 2012 Jun 28;486(7404):554-8.

doi: 10.1038/nature11147.

Julian P Vivian, Nadine L Dudek, Lyudmila Kostenko, Zhenjun Chen, Mandvi Bharadwaj, John J Miles, Lars Kjer-Nielsen, Stephanie Gras, Nicholas A Williamson, Scott R Burrows, Anthony W Purcell, Jamie Rossjohn, James McCluskey

Affiliations

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

Patricia T Illing et al. Nature. 2012.

Abstract

Human leukocyte antigens (HLAs) are highly polymorphic proteins that initiate immunity by presenting pathogen-derived peptides to T cells. HLA polymorphisms mostly map to the antigen-binding cleft, thereby diversifying the repertoire of self-derived and pathogen-derived peptide antigens selected by different HLA allotypes. A growing number of immunologically based drug reactions, including abacavir hypersensitivity syndrome (AHS) and carbamazepine-induced Stevens-Johnson syndrome (SJS), are associated with specific HLA alleles. However, little is known about the underlying mechanisms of these associations, including AHS, a prototypical HLA-associated drug reaction occurring exclusively in individuals with the common histocompatibility allele HLA-B*57:01, and with a relative risk of more than 1,000 (refs 6, 7). We show that unmodified abacavir binds non-covalently to HLA-B*57:01, lying across the bottom of the antigen-binding cleft and reaching into the F-pocket, where a carboxy-terminal tryptophan typically anchors peptides bound to HLA-B*57:01. Abacavir binds with exquisite specificity to HLA-B*57:01, changing the shape and chemistry of the antigen-binding cleft, thereby altering the repertoire of endogenous peptides that can bind HLA-B*57:01. In this way, abacavir guides the selection of new endogenous peptides, inducing a marked alteration in 'immunological self'. The resultant peptide-centric 'altered self' activates abacavir-specific T-cells, thereby driving polyclonal CD8 T-cell activation and a systemic reaction manifesting as AHS. We also show that carbamazepine, a widely used anti-epileptic drug associated with hypersensitivity reactions in HLA-B*15:02 individuals, binds to this allotype, producing alterations in the repertoire of presented self peptides. Our findings simultaneously highlight the importance of HLA polymorphism in the evolution of pharmacogenomics and provide a general mechanism for some of the growing number of HLA-linked hypersensitivities that involve small-molecule drugs.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Immunity. 2009 Dec 18;31(6):897-908 - PubMed
    1. J Immunol. 2001 Jan 15;166(2):1016-27 - PubMed
    1. Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1355-63 - PubMed
    1. FEBS Lett. 2002 Sep 11;527(1-3):27-32 - PubMed
    1. Pharmacogenomics. 2004 Mar;5(2):203-11 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources